Risk factors for significant hepatic fibrosis in alcoholic liver disease and construction of a nomogram prediction model. [PDF]
Jin M, Zhou J, He DM, Chen FL, Li HW.
europepmc +1 more source
Experimental Study of YaJieShaBa Antialcoholic Hepatic Fibrosis Through TGF-β1/Smad Signaling Pathway. [PDF]
Zhang L +9 more
europepmc +1 more source
Huanggan decoction ameliorates cholestatic hepatic fibrosis in rats via TGF-β1/Smad3 signaling pathway. [PDF]
Lei Y +7 more
europepmc +1 more source
Chronic TBPH Exposure Drives the Transition from Steatosis to Hepatic Fibrosis via Lipid Droplet Dysregulation in Zebrafish. [PDF]
Liu Y, Pan D, Li M, Guo W.
europepmc +1 more source
Clinical validation of T1ρ mapping for the assessment of hepatic fibrosis in patients with chronic liver disease. [PDF]
Mesropyan N +12 more
europepmc +1 more source
Modeling hepatic fibrosis in TP53 knockout iPSC-derived human liver organoids. [PDF]
Karabicici M +8 more
europepmc +1 more source
EMP1 + hepatic stellate cells drive hepatic fibrosis progression to hepatocellular carcinoma and predict prognosis. [PDF]
You J +9 more
europepmc +1 more source
Congenital Hepatic Fibrosis and/or Autosomal Recessive Polycystic Kidney Disease: A Single-center Experience. [PDF]
Altay D, Yel S, Dursun İ, Arslan D.
europepmc +1 more source
Ginkgolic acid attenuates echinococcus granulosus infection-induced hepatic fibrosis by inhibiting Smad4 SUMOylation. [PDF]
Chen Q +9 more
europepmc +1 more source
METTL3 inhibition attenuates AFB<sub>1</sub>-induced hepatic fibrosis by suppressing m<sup>6</sup>A-mediated hepatic stellate cell activation. [PDF]
Zhao Y, Feng Y, Yuan W, Zhang T, Zhao R.
europepmc +1 more source

